1989
DOI: 10.1016/0264-410x(89)90196-5
|View full text |Cite
|
Sign up to set email alerts
|

Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
15
0

Year Published

1990
1990
1999
1999

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(15 citation statements)
references
References 6 publications
0
15
0
Order By: Relevance
“…The monolayers were then covered with 5 ml of 1% Noble agar (Sigma) in EMEM supplemented with 2% FCS. Viral plaques were visualized after 4 days by staining with neutral red (Barrett et al, 1989). TCIDso assays were made using HeLa cells.…”
Section: Cells and Virusmentioning
confidence: 99%
See 1 more Smart Citation
“…The monolayers were then covered with 5 ml of 1% Noble agar (Sigma) in EMEM supplemented with 2% FCS. Viral plaques were visualized after 4 days by staining with neutral red (Barrett et al, 1989). TCIDso assays were made using HeLa cells.…”
Section: Cells and Virusmentioning
confidence: 99%
“…Both parent and HeLa passage 6 (p6) viruses were tested in plaque reduction neutralization tests, which were carried out on LLC-MK2 monolayers, as described in Barrett et al (1989).…”
Section: Cells and Virusmentioning
confidence: 99%
“…A plaque assay procedure was used to determine the virus infectivity titre (Barrett et al, 1989); LLC-MK2 cells were used for all assays.…”
Section: Infectivity Titrationmentioning
confidence: 99%
“…MAb B39 represents one of a panel of E protein-reactive MAbs raised against the 17DD substrain vaccine virus manufactured in Brazil (17DD-Braz), characterized previously as a YF type-specific MAb (Ledger et al, 1992). In plaque reduction neutralization tests (PRNTs), (Barrett et al, 1989).…”
mentioning
confidence: 99%
“…performed in monolayers of SW13 cells as described by Barrett et al (1989), MAb B39 neutralized the World Health Organization secondary seed lot of the 17D-204 substrain vaccine virus (17D-204-WHO) to high titre (4 log "! units), but failed to neutralize any of the other YF virus strains tested, including 17DD-Braz (Barrett et al, 1989).…”
mentioning
confidence: 99%